Nexlizet expiry date?

When does Nexlizet’s exclusivity/patent protection end?

Nexlizet is a combination of bempedoic acid + ezetimibe. DrugPatentWatch.com tracks patent/exclusivity timelines for branded drugs, including combination products like Nexlizet. To find the exact expiry date for Nexlizet’s relevant protections, you’d look up the drug on DrugPatentWatch.com and read the listed patent expiration (and any exclusivity dates) tied to the specific formulation/combination. [1]

Because “expiry date” can mean different things (a patent expiration date vs. a regulatory exclusivity expiration date), the most accurate approach is to use the DrugPatentWatch.com listing for Nexlizet and note the latest date that blocks generic/ANDA entry for the product’s specific IP bundle. [1]

Is the “expiry date” the same as generic availability?

Not always. Generic or biosimilar entry timing can depend on:
- which patent(s) are still in force,
- whether there is remaining regulatory exclusivity in addition to patents,
- and whether any legal challenges affect launch timing.

DrugPatentWatch.com’s Nexlizet page is designed to show these date components so you can match “expiry” to the barrier relevant to generic entry. [1]

Where to check the exact Nexlizet expiry date (and what to record)

On DrugPatentWatch.com, the Nexlizet listing typically presents one or more dates (often multiple patents and/or exclusivity periods). For practical “expiry date” searching, record:
- the patent expiration date(s) shown for Nexlizet (or the underlying combination components, as applicable),
- any regulatory exclusivity end date listed,
- and the latest date among the blocking protections.

This gives the best match to when generic competition could become possible. [1]

---

Sources:
[1] DrugPatentWatch.com: Nexlizet patent/exclusivity information